世界の咳止めシロップ市場2020年-2027年:製品タイプ別(去痰薬、咳止め薬/鎮咳薬、併用薬)、年齢層別、流通チャネル別

◆英語タイトル:Cough Syrup Market by Product Type (Expectorants, Cough Suppressants/Antitussives, and Combination Medications), Age Group (Pediatric and Adult), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2020-2027
◆商品コード:AMR21AP008
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2021年2月24日
◆ページ数:240
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD6,168 ⇒換算¥678,480見積依頼/購入/質問フォーム
5 UserUSD6,929 ⇒換算¥762,190見積依頼/購入/質問フォーム
Enterprise UserUSD9,663 ⇒換算¥1,062,930見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Allied Market Research社の本調査レポートでは、世界の咳止めシロップ市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、製品タイプ別(去痰薬、咳止め薬/鎮咳薬、併用薬)分析、年齢層別(小児、成人)分析、流通チャネル別(小売薬局、病院薬局、オンライン薬局)分析、地域別分析、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の咳止めシロップ市場規模:製品タイプ別(去痰薬、咳止め薬/鎮咳薬、併用薬)
・世界の咳止めシロップ市場規模:年齢層別(小児、成人)
・世界の咳止めシロップ市場規模:流通チャネル別(小売薬局、病院薬局、オンライン薬局)
・世界の咳止めシロップ市場規模:地域別
・企業情報
【レポートの概要】

The global cough syrup market was valued at $5,232.73 million in 2019, and is projected to reach $6,108.25 million by 2027, registering a CAGR of 2.8% from 2020 to 2027.

Cough is one of the most common symptoms for which patients seek medical attention from primary care physicians and pulmonologists. Cough is an important defensive reflex that enhances the clearance of secretions and particles from the airways and protects the lower airways from foreign materials. Therapeutic suppression of cough may be either disease-specific or symptom related. The potential benefits of an early treatment of cough could include the prevention of the vicious cycle of cough.

The growth of the global cough syrup market is majorly driven by rise in respiratory disorders. In addition, increase in geriatric population and immense air pollution further drive the growth of the market. However, misuse of cough syrup and stringent regulatory framework hinder the market growth. Conversely, high market potential in untapped emerging economies is expected to provide lucrative growth opportunities for the market growth.

The cough syrup market is segmented on the basis of product type, age group, distribution channel, and region. By product, the market is divided into expectorants, cough suppressants/antitussives, and combination medications. On the basis of age group, the cough syrup market is bifurcated into pediatric and adult. By distribution channel, the market is segmented into retail pharmacy, hospital pharmacy, and online pharmacy. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
 This report entails a detailed quantitative analysis along with the current global cough syrup market trends from 2020 to 2027 to identify the prevailing opportunities along with the strategic assessment.
 The market forecast is studied from 2020 to 2027.
 The market size and estimations are based on a comprehensive analysis of key developments in the industry.
 A qualitative analysis based on innovative products facilitates strategic business planning.
 The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global cough syrup market.

KEY MARKET SEGMENTS
By Product Type
• Expectorants
• Cough Suppressants/Antitussives
• Combination Medications

By Age Group
• Pediatric
• Adult

By Distribution Channel
• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o France
o Germany
o Spain
o Italy
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

KEY MARKET PLAYERS
• Novartis AG, Pfizer, Inc.
• Merck KGaA
• GlaxoSmithKline PLC
• Johnson & Johnson Services, Inc.
• Acella Pharmaceuticals, LLC
• Reckitt Benckiser Group PLC
• Sanofi
• Procter & Gamble
• Abbott Laboratories

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
1.4.4.Primary research

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top player positioning, 2019

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increasing number of patients suffering from respiratory disease
3.4.1.2.Advancements in cough syrup product
3.4.1.3.Rise in elderly population

3.4.2.Restraints

3.4.2.1.Cough syrup abuse
3.4.2.2.Stringent rules and regulation in the developed countries

3.4.3.Opportunity

3.4.3.1.Emerging market

3.5.COVID-19 impact analysis for cough syrup market

CHAPTER 4:COUGH SYRUP MARKET, BY PRODUCT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Expectorants

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Cough suppressants

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Combination medications

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:COUGH SYRUP MARKET, BY AGE GROUP

5.1.Overview

5.1.1.Market size and forecast

5.2.Pediatric

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Adult

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

CHAPTER 6:COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail Pharmacy

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Hospital Pharmacy

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Online Pharmacy

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:COUGH SYRUP MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America Cough syrup market, by country

7.2.2.1.U.S. Market size and forecast, by product type
7.2.2.2.U.S. Market size and forecast, by age group
7.2.2.3.U.S. Market size and forecast, by distribution channel
7.2.2.4.Canada Market size and forecast, by product type
7.2.2.5.Canada Market size and forecast, by age group
7.2.2.6.Canada Market size and forecast, by distribution channel
7.2.2.7.Mexico Market size and forecast, by product type
7.2.2.8.Mexico Market size and forecast, by age group
7.2.2.9.Mexico Market size and forecast, by distribution channel

7.2.3.North America market size and forecast, by product type
7.2.4.North America market size and forecast, by age group
7.2.5.North America Market size and forecast, by distribution channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Cough syrup market, by country

7.3.2.1.Germany Market size and forecast, by product type
7.3.2.2.Germany Market size and forecast, by age group
7.3.2.3.Germany Market size and forecast, by distribution channel
7.3.2.4.France Market size and forecast, by product type
7.3.2.5.France Market size and forecast, by age group
7.3.2.6.France Market size and forecast, by distribution channel
7.3.2.7.UK Market size and forecast, by product type
7.3.2.8.UK Market size and forecast, by age group
7.3.2.9.UK Market size and forecast, by distribution channel
7.3.2.10.Italy Market size and forecast, by product type
7.3.2.11.Italy Market size and forecast, by age group
7.3.2.12.Italy Market size and forecast, by distribution channel
7.3.2.13.Spain Market size and forecast, by product type
7.3.2.14.Spain Market size and forecast, by age group
7.3.2.15.Spain Market size and forecast, by distribution channel
7.3.2.16.Rest of Europe Market size and forecast, by product type
7.3.2.17.Rest of Europe Market size and forecast, by age group
7.3.2.18.Rest of Europe Market size and forecast, by distribution channel

7.3.3.Europe market size and forecast, by product type
7.3.4.Europe market size and forecast, by age group
7.3.5.Europe Market size and forecast, by distribution channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific Cough syrup market, by country

7.4.2.1.Japan Market size and forecast, by product type
7.4.2.2.Japan Market size and forecast, by age group
7.4.2.3.Japan Market size and forecast, by distribution channel
7.4.2.4.China Market size and forecast, by product type
7.4.2.5.China Market size and forecast, by age group
7.4.2.6.China Market size and forecast, by distribution channel
7.4.2.7.Australia Market size and forecast, by product type
7.4.2.8.Australia Market size and forecast, by age group
7.4.2.9.Australia Market size and forecast, by distribution channel
7.4.2.10.India Market size and forecast, by product type
7.4.2.11.India Market size and forecast, by age group
7.4.2.12.India Market size and forecast, by distribution channel
7.4.2.13.Rest of Asia-Pacific Market size and forecast, by product type
7.4.2.14.Rest of Asia-Pacific Market size and forecast, by age group
7.4.2.15.Rest of Asia-Pacific Market size and forecast, by distribution channel

7.4.3.Asia-Pacific market size and forecast, by product type
7.4.4.Asia-Pacific market size and forecast, by age group
7.4.5.Asia-Pacific Market size and forecast, by distribution channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Cough syrup market, by country

7.5.2.1.Brazil Market size and forecast, by product type
7.5.2.2.Brazil Market size and forecast, by age group
7.5.2.3.Brazil Market size and forecast, by distribution channel
7.5.2.4.Saudi Arabia Market size and forecast, by product type
7.5.2.5.Saudi Arabia Market size and forecast, by age group
7.5.2.6.Saudi Arabia Market size and forecast, by distribution channel
7.5.2.7.South Africa Market size and forecast, by product type
7.5.2.8.South Africa Market size and forecast, by age group
7.5.2.9.South Africa Market size and forecast, by distribution channel
7.5.2.10.Rest of LAMEA Market size and forecast, by product type
7.5.2.11.Rest of LAMEA Market size and forecast, by age group
7.5.2.12.Rest of LAMEA Market size and forecast, by distribution channel

7.5.3.LAMEA market size and forecast, by product type
7.5.4.LAMEA market size and forecast, by age group
7.5.5.LAMEA Market size and forecast, by distribution channel

CHAPTER 8:COMPANY PROFILES

8.1.Abbott Laboratories

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.Acella Pharmaceuticals, LLC

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio

8.3.GlaxoSmithKline plc

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.Johnson & Johnson services Inc.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.Merck KGaA

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.Novartis International AG

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.Pfizer Inc.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.Procter & Gamble

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.Reckitt Benckiser Group Plc.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.Sanofi

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 02.COUGH SYRUP MARKET FOR EXPECTORANTS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.COUGH SYRUP MARKET FOR COUGH SUPPRESSANTS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.COUGH SYRUP MARKET FOR COMBINATION MEDICATIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 06.COUGH SYRUP MARKET FOR PEDIATRIC, BY REGION, 2019–2027 ($MILLION)
TABLE 07.COUGH SYRUP MARKET FOR ADULT, BY REGION, 2019–2027 ($MILLION)
TABLE 08.COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 09.COUGH SYRUP MARKET FOR RETAIL PHARMACY, BY REGION, 2019–2027 ($MILLION)
TABLE 10.COUGH SYRUP MARKET FOR HOSPITAL PHARMACY, BY REGION, 2019–2027 ($MILLION)
TABLE 11.COUGH SYRUP MARKET FOR ONLINE PHARMACY, BY REGION, 2019–2027 ($MILLION)
TABLE 12.COUGH SYRUP MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 14.U.S. COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 15.U.S. COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 16.U.S. COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 17.CANADA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 18.CANADA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 19.CANADA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 20.MEXICO COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 21.MEXICO COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 22.MEXICO COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 24.NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 25.NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 26.EUROPE COUGH SYRUP MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 27.GERMANY COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 28.GERMANY COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 29.GERMANY COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 30.FRANCE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 31.FRANCE COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 32.FRANCE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 33.UK COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 34.UK COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 35.UK COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 36.ITALY COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 37.ITALY COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 38.ITALY COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 39.SPAIN COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 40.SPAIN COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 41.SPAIN COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 42.REST OF EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 43.REST OF EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 44.REST OF EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 45.EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 46.EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 47.EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 48.ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 49.JAPAN COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 50.JAPAN COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 51.JAPAN COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 52.CHINA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 53.CHINA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 54.CHINA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 55.AUSTRALIA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 56.AUSTRALIA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 57.AUSTRALIA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 58.INDIA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 59.INDIA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 60.INDIA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 61.REST OF ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 62.REST OF ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 63.REST OF ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 64.ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 65.ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 66.ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 67.LAMEA COUGH SYRUP MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 68.BRAZIL COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 69.BRAZIL COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 70.BRAZIL COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 71.SAUDI ARABIA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 72.SAUDI ARABIA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 73.SAUDI ARABIA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 74.SOUTH AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 75.SOUTH AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 76.SOUTH AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 77.REST OF LAMEA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 78.REST OF LAMEA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 79.REST OF LAMEA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 80.LAMEA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 81.LAMEA COUGH SYRUP MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 82.LAMEA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 83.ABBOTT: COMPANY SNAPSHOT
TABLE 84.ABBOTT: OPERATING SEGMENTS
TABLE 85.ABBOTT: PRODUCT PORTFOLIO
TABLE 86.ACELLA PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 87.ACELLA PHARMACEUTICALS: OPERATING SEGMENTS
TABLE 88.ACELLA PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 89.GSK: COMPANY SNAPSHOT
TABLE 90.GSK: OPERATING SEGMENTS
TABLE 91.GSK: PRODUCT PORTFOLIO
TABLE 92.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 93.J&J: OPERATING SEGMENTS
TABLE 94.J&J: PRODUCT PORTFOLIO
TABLE 96.MERCK: OPERATING SEGMENTS
TABLE 97.MERCK: PRODUCT PORTFOLIO
TABLE 98.NVS: COMPANY SNAPSHOT
TABLE 99.NOVARTIS: OPERATING SEGMENTS
TABLE 100.NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 101.PFIZER: COMPANY SNAPSHOT
TABLE 102.PFIZER: OPERATING SEGMENTS
TABLE 103.PFIZER: PRODUCT PORTFOLIO
TABLE 104.P&G: COMPANY SNAPSHOT
TABLE 105.P&G: OPERATING SEGMENTS
TABLE 106.P&G: PRODUCT PORTFOLIO
TABLE 107.RB: COMPANY SNAPSHOT
TABLE 108.RB: OPERATING SEGMENTS
TABLE 109.RB : PRODUCT PORTFOLIO
TABLE 110.SANOFI: COMPANY SNAPSHOT
TABLE 111.SANOFI: OPERATING SEGMENTS
TABLE 112.SANOFI: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.COUGH SYRUP MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS IN COUGH SYRUPMARKET
FIGURE 03.TOP PLAYER POSITIONING, 2019
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE THREAT OF SUBSTITUTION
FIGURE 08.MODERATE COMPETITIVE RIVALRY
FIGURE 09.DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 10.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR EXPECTORANTS BY COUNTRY, 2019–2027 (%)
FIGURE 11.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR COUGH SUPPRESSANTS BY COUNTRY, 2019–2027 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR COMBINATION MEDICATIONS BY COUNTRY, 2019–2027 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR PEDIATRIC BY COUNTRY, 2019–2027 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR ADULT BY COUNTRY, 2019–2027 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR RETAIL PHARMACY, BY COUNTRY, 2019–2027 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR HOSPITAL PHARMACY, BY COUNTRY, 2019–2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF COUGH SYRUP MARKET, FOR ONLINE PHARMACY BY COUNTRY, 2019–2027 (%)
FIGURE 18.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 19.ABBOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 20.ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 21.GSK: NET SALES, 2017–2019 ($MILLION)
FIGURE 22.GSK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 23.GSK: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 24.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 25.J&J: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 26.J&J: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 27.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 28.MERCK: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29.NOVARTIS: NET SALES, 2018–2019 ($MILLION)
FIGURE 30.NOVARTIS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 31.NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 32.PFIZER: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.PFIZER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.PFIZER: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 35.P&G: NET SALES, 2017–2019 ($MILLIO)
FIGURE 36.RB: NET SALES, 2018–2019 ($MILLION)
FIGURE 37.RB: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 38.RB: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 39.SANOFI: NET SALES, 2017 TO 2019 ($MILLION)
FIGURE 40.SANOFI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.SANOFI: REVENUE SHARE BY GEOGRAPHY, 2019 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の咳止めシロップ市場2020年-2027年:製品タイプ別(去痰薬、咳止め薬/鎮咳薬、併用薬)、年齢層別、流通チャネル別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆